In relation to breast cancer, most of the studies conducted so far were performed on triple-negative breast tumors, whereas studies in ER+ and human epidermal growth factor receptor 2 positive (HER2+) tumors are still scarce [29,36,37]. The gene discussed is ESR1; the disease is breast cancer.